TD Cowen has initiated coverage on Option Care Health Inc (OPCH) with a Hold rating as of October 1, 2025. This marks the firm's first assessment of the company's investment potential.
Option Care Health, headquartered in Bannockburn, Illinois, provides home and alternate site infusion services. The company employs 6,015 full-time staff and operates a network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. Its therapy portfolio includes a variety of treatments, such as anti-infectives infusion and nutrition support.
Currently, Option Care Health has a market capitalization of $4.5 billion, with a price-to-earnings ratio of 21.52 and earnings per share of 1.26. The company is expected to report its next earnings on October 30, 2025, with an estimated EPS of $0.44 and revenue of $1.4 billion.
Analyst ratings and price targets provide insights based on research and financial models. While they can inform investment decisions, they should be considered alongside company fundamentals and market conditions. As of November 1, 2025, the consensus among analysts is a Buy, with 6 Strong Buy, 9 Buy, and 2 Hold ratings.
This update provides insight into the evolving landscape of analyst opinions on Option Care Health, reflecting the broader dynamics within the health care sector.